Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.41 |
| ▸ | PPARD | Q03181 | 5/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.39 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL637417 | 0.87 | SLC1A3 (0.37) | MAPTSLC1A2SLC1A1TSHRALDH1A1 | |
| SCHEMBL724845 | 0.74 | SLC1A3 (0.39) | MAPTSLC1A2SLC1A1TSHRALDH1A1 | |
| SCHEMBL13698690 | 0.71 | THRB (0.33) | CA2MAPK1MAPTPPARAALDH1A1 | |
| SCHEMBL5527513 | 0.71 | FFAR1 (0.39) | FFAR1SLC1A2SLC1A1MEN1KMT2A | |
| SCHEMBL7783013 | 0.70 | ALDH1A1 (0.36) | MAPTSLC1A2SLC1A1TSHRALDH1A1 | |
| SCHEMBL6560782 | 0.69 | ALDH1A1 (0.35) | MAPTTSHRALDH1A1 | |
| SCHEMBL8072808 | 0.68 | HSPD1 (0.56) | CA2MAPK1GPR84FFAR1PPARD | |
| SCHEMBL2137285 | 0.68 | GPR84 (0.52) | CA2MAPK1GPR84FFAR1PPARD | |
| Hexane SCHEMBL3187009 | 0.67 | CA2 (0.81) | CA2MAPK1GPR84FFAR1PPARD | |
| SCHEMBL21247622 | 0.67 | HSPD1 (0.59) | CA2MAPK1GPR84FFAR1PPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10647737-B2 | Sulfated-glycolipids as adjuvants for vaccines | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2020-05-12 | — | — | US | disclosed |
| EP-3166957-B1 | SULFATED-GLYCOLIPIDS AS ADJUVANTS FOR VACCINES | NAT RES COUNCIL CANADA (CA) | 2019-11-13 | — | — | EP | disclosed |
| US-20170158728-A1 | SULFATED-GLYCOLIPIDS AS ADJUVANTS FOR VACCINES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2017-06-08 | — | — | US | disclosed |
| EP-3166957-A1 | SULFATED-GLYCOLIPIDS AS ADJUVANTS FOR VACCINES | National Research Council of Canada (CA) | 2017-05-17 | — | — | EP | disclosed |
| WO-2016004512-A1 | SULFATED-GLYCOLIPIDS AS ADJUVANTS FOR VACCINES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2016-01-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10647737-B2 | Sulfated-glycolipids as adjuvants for vaccines | DEGS1, SGMS1, CD4 | CA2 1746/4885MAPK1 1454/4885GPR84 3243/4885 |
| US-20170158728-A1 | SULFATED-GLYCOLIPIDS AS ADJUVANTS FOR VACCINES | DEGS1, SGMS1, CD4 | CA2 1746/4885MAPK1 1454/4885GPR84 3243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.